15 results
10-K
2020 FY
ORIC
ORIC Pharmaceuticals Inc
23 Mar 21
Annual report
4:21pm
/kg IP, Q3D×8), cortisol (100 mg/L in drinking water, ad libitum) or ORIC-101 (75 mg/kg of ORIC-101, PO, BID) starting on Day 0 for the duration
8-K
EX-99.2
ORIC
ORIC Pharmaceuticals Inc
11 Jan 21
ORIC Pharmaceuticals Provides Corporate Update and Highlights Key 2021 Milestones
6:36am
. Mice were treated with paclitaxel (20 mg/kg IP, Q3D×8), cortisol (100 mg/L in drinking water, ad libitum) and/or ORIC-101 (75 mg/kg of ORIC-101, PO, BID
424B4
ORIC
ORIC Pharmaceuticals Inc
13 Nov 20
Prospectus supplement with pricing info
5:21pm
and ORIC-101. Mice were treated with paclitaxel (20 mg/kg IP, Q3D×8), cortisol (100 mg/L in drinking water, ad libitum) or ORIC-101 (75 mg/kg of ORIC
DRS
3xpdc8 dreoba
20 Jul 20
Draft registration statement
12:00am
424B4
ud5k6k57emqmoktjo
24 Apr 20
Prospectus supplement with pricing info
5:04pm
S-1
EX-10.11
oaeb p2cocl
28 Feb 20
IPO registration
5:32pm
S-1
3zao2via0kvhx2bokfu
28 Feb 20
IPO registration
5:32pm
DRS/A
ck5itbzjjd5o
24 Jan 20
Draft registration statement (amended)
12:00am
DRS
EX-10.10
8vqoabb6fxu5325dibb
13 Dec 19
Draft registration statement
12:00am
DRS
0p5v07
13 Dec 19
Draft registration statement
12:00am
- Prev
- 1
- Next